Filing Details

Accession Number:
0001144204-16-106469
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-06-02 15:24:58
Reporting Period:
2016-05-31
Filing Date:
2016-06-02
Accepted Time:
2016-06-02 15:24:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1609351 Spark Therapeutics Inc. ONCE () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1590102 Anand Mehra Sofinnova Ventures
3000 Sand Hill Road, 4-250
Menlo Park CA 94025
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-05-31 500 $60.00 1,434,966 No 4 S Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See footnote
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Sofinnova Venture Partners VIII, L.P. ("SVP VIII") on October 8, 2015.
  2. The securities are owned directly by SVP VIII. Sofinnova Management VIII, L.L.C. ("SM VIII"), the general partner of SVP VIII, and Anand Mehra, a director of the Issuer, James I. Healy, and Michael Powell, the managing members of SM VIII, may be deemed to have shared voting and dispositive power over the shares owned by SVP VIII. Such persons and entities disclaim beneficial ownership over the shares owned by SVP VIII except to the extent of any pecuniary interest therein.